311 related articles for article (PubMed ID: 20724373)
21. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract][Full Text] [Related]
22. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells.
Um HJ; Min KJ; Kim DE; Kwon TK
Biochem Biophys Res Commun; 2012 Oct; 427(1):24-9. PubMed ID: 22982675
[TBL] [Abstract][Full Text] [Related]
23. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
24. Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway.
Liu X; Li Y; Ma Q; Wang Y; Song AL
Med Sci Monit; 2019 Sep; 25():6855-6863. PubMed ID: 31512681
[TBL] [Abstract][Full Text] [Related]
25. Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells.
Stan SD; Zeng Y; Singh SV
Nutr Cancer; 2008; 60 Suppl 1(Suppl 1):51-60. PubMed ID: 19003581
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
28. Withaferin A inhibits breast cancer-induced osteoclast differentiation.
Hahm ER; Kim SH; Singh SV
Mol Carcinog; 2023 Jul; 62(7):1051-1061. PubMed ID: 37067392
[TBL] [Abstract][Full Text] [Related]
29. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
[TBL] [Abstract][Full Text] [Related]
30. Withaferin A suppressed hepatocellular carcinoma progression through inducing IGF2BP3/FOXO1/JAK2/STAT3 pathway-mediated ROS production.
Li J; Ge M; Deng P; Wu X; Shi L; Yang Y
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):40-48. PubMed ID: 37671837
[TBL] [Abstract][Full Text] [Related]
31. STAT3 can be activated through paracrine signaling in breast epithelial cells.
Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
[TBL] [Abstract][Full Text] [Related]
32. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
33. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
Munagala R; Kausar H; Munjal C; Gupta RC
Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
[TBL] [Abstract][Full Text] [Related]
34. Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Jang BH; Shin YC; Ko SG
Anticancer Res; 2014 Jun; 34(6):2869-82. PubMed ID: 24922650
[TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
36. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797
[TBL] [Abstract][Full Text] [Related]
37. Proinflammatory Cytokines IL-6 and TNF-
Chung SS; Wu Y; Okobi Q; Adekoya D; Atefi M; Clarke O; Dutta P; Vadgama JV
Mediators Inflamm; 2017; 2017():5958429. PubMed ID: 28676732
[TBL] [Abstract][Full Text] [Related]
38. Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo.
Liu Z; Ge X; Gu Y; Huang Y; Liu H; Yu M; Liu Y
Biomed Pharmacother; 2020 Jan; 121():109502. PubMed ID: 31707351
[TBL] [Abstract][Full Text] [Related]
39. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
Singh KB; Hahm ER; Kim SH; Singh SV
Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
[TBL] [Abstract][Full Text] [Related]
40. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]